Cullinan Therapeutics Inc (CGEM) returns
Cullinan Therapeutics returns over 5 years
$1,000 invested in Cullinan Therapeutics five years ago was worth $676.42 at the close on October 30, 2026, with dividends reinvested: an average return of -7.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -2.1% | — | $979.15 | -0.9% |
| 3 months | -14.2% | — | $857.88 | +2.1% |
| Year to date | +45.2% | — | $1,452 | +11.7% |
| 1 year | +98.8% | — | $1,988 | +12.4% |
| 3 years | +73.0% | +20.0% | $1,730 | +88.5% |
| 5 years | -32.4% | -7.5% | $676.42 | +76.0% |
Cullinan Therapeutics return by calendar year
| Year | CGEM | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +45.2% | +11.7% | +33.5% |
| 2025 | -15.0% | +17.7% | -32.7% |
| 2024 | +19.5% | +24.9% | -5.4% |
| 2023 | -3.4% | +26.2% | -29.6% |
| 2022 | -31.6% | -18.2% | -13.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Cullinan Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.